CENGİZ, H. Et Al. 2017. DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells. 42.FEBS Congress .

CENGİZ, H., KOÇDOR, M. A., AYDIN, S., & KOÇDOR, H., (2017). DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells . 42.FEBS Congress

CENGİZ, HAKAN Et Al. "DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells," 42.FEBS Congress, 2017

CENGİZ, HAKAN Et Al. "DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells." 42.FEBS Congress , 2017

CENGİZ, H. Et Al. (2017) . "DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells." 42.FEBS Congress .

@conferencepaper{conferencepaper, author={HAKAN CENGİZ Et Al. }, title={DEGUELIN, a novel anti-cancer agent, inhibitstumor aggressiveness and increases docetaxelefficacy in lung cancer cells}, congress name={42.FEBS Congress}, city={}, country={}, year={2017}}